Cargando…
A Pilot Study to Evaluate Early Predictive Value of Thorax Perfusion-CT in Advanced NSCLC
SIMPLE SUMMARY: The use of targeted drugs has brought about the development of new imaging techniques which are able to assess in vivo processes and changes in vascularization parameters can be captured as part of the antitumor response to antiangiogenic therapies. This pilot study (IMPACT trial, NC...
Autores principales: | Aya, Francisco, Benegas, Mariana, Viñolas, Nuria, Reyes, Roxana, Vollmer, Ivan, Arcocha, Ainara, Sánchez, Marcelo, Reguart, Noemi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583202/ https://www.ncbi.nlm.nih.gov/pubmed/34771728 http://dx.doi.org/10.3390/cancers13215566 |
Ejemplares similares
-
Prospective Evaluation of Single Nucleotide Variants by Two Different Technologies in Paraffin Samples of Advanced Non-Small Cell Lung Cancer Patients
por: Marin, Elba, et al.
Publicado: (2020) -
Usefulness of Two Independent DNA and RNA Tissue-Based Multiplex Assays for the Routine Care of Advanced NSCLC Patients
por: Marin, Elba, et al.
Publicado: (2020) -
Molecular characterization of advanced non-small cell lung cancer patients by cfDNA analysis: experience from routine laboratory practice
por: González de Aledo-Castillo, José Manuel, et al.
Publicado: (2021) -
182P Impact of SARS CoV 2 outbreak in the molecular diagnosis of advanced NSCLC: A retrospective comparative cohort study
por: Marin, E., et al.
Publicado: (2021) -
Technical Evaluation of the COBAS EGFR Semiquantitative Index (SQI) for Plasma cfDNA Testing in NSCLC Patients with EGFR Exon 19 Deletions
por: González de Aledo-Castillo, José Manuel, et al.
Publicado: (2021)